People · Operator
Named in public records as an officer, director or promoter · active 2014–2021 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Telcare, Inc. | — | Other | Series B | $71.6M | $576.6M | 2014 |
| Avivomed Inc. | — | Biotechnology | Series B | $20.1M | $448.7M | 2021 |
Casper C. De Clercq at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Casper C. De Clercq on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Flynn | 1 | 8 |
| Scott Carter | 1 | 6 |
| John Dwyer | 1 | 5 |
| Mudit K. Jain | 1 | 4 |
| Jonathan Javitt | 1 | 3 |
| David Bjork | 1 | 2 |
| Ketan K. Patel | 1 | 2 |
| Stephen Masson | 1 | 1 |
| Theresa C. Pappas | 1 | 1 |
| Douglas C. Reed | 1 | 1 |
| Jonathan C. Javitt | 1 | 1 |
| Scott C. Carter | 1 | 1 |
| Patrick C. Flynn | 1 | 1 |
| Kenneth C. Melani | 1 | 1 |
| John R. Dwyer, Jr. | 1 | 1 |
| Andrew Flanagan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.